SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-042783
Filing Date
2024-04-02
Accepted
2024-04-02 21:56:01
Documents
2
Group Members
DOUGLAS D. FRENCHJOE H. CUNNINGHAMKEVIN M. LALANDESANTE ACCEL VENTURES IV, LLCSANTE HEALTH VENTURES I ANNEX FUND, LPSANTE HEALTH VENTURES IV, L.P.SHV ANNEX SERVICES, LPSHV MANAGEMENT SERVICES IV, LLCSHV MANAGEMENT SERVICES IV, LPSHV MANAGEMENT SERVICES, L

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2410755d1_sc13da.htm SC 13D/A 232676
2 EXHIBIT 1 tm2410755d1_ex1.htm EX-1 25161
  Complete submission text file 0001104659-24-042783.txt   260089
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81377 | Film No.: 24816727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SHV MANAGEMENT SERVICES LP 300 WEST SIXTH STREET, SUITE 2300 AUSTIN TX 78701
Business Address C/O SHV MANAGEMENT SERVICES LP 300 WEST SIXTH STREET, SUITE 2300 AUSTIN TX 78701 512-721-1200
SANTE HEALTH VENTURES I LP (Filed by) CIK: 0001433076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A